Positive high-level results from the TROPION-Lung01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the dual primary endpoint of...
Corbus Pharmaceuticals Holdings, Inc, a precision oncology company, announced that it has entered into an exclusive licensing agreement with CSPC Megalith Biopharmaceutical Co., Ltd,...
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited committed to cutting edge technology innovations, and providing a total solution from "Idea to IND"...
Pony.ai, a leading global autonomous driving technology company, announced that its Autonomous Driving Controller (ADC), powered by the NVIDIA DRIVE Hyperion compute architecture (DRIVE...
CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the...
